Panacea Biotec has informed about a Press Release dated March 28, 2016 titled ‘Panacea Biotec Launches - CABAPAN, A Cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)’.
The above information is a part of company’s filings submitted to BSE.